Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG + Cyclosporine in MDS
NCT00016419Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Aug 2001
- Primary completion
- Jul 2003
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of antithymocyte globulin rabbit and cyclosporine in myelodysplastic syndrome (MDS), sponsored by SWOG Cancer Research Network. Primary endpoint: Total Response. Started Aug 2001; status: completed.
02
Drugs
antithymocyte globulin rabbitcyclosporine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00016419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00016419.